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Transcutaneous electrical acupoint stimulation 
improves the outcomes of in vitro fertilization: A 
prospective, randomized and controlled study. 
 
 
Abstract 
Objectives: To explore whether transcutaneous electrical acupoint stimulation (TEAS) can 
improve the outcomes of in vitro fertilization (IVF).  
Design: A prospective, randomized and controlled study. 
Setting: IVF center in a university hospital. 
Participants: Four hundred and eighty-one infertile patients with bilateral tubal blockage 
who were referred for IVF. Patients were randomized into four groups. 
Intervention: TEAS was administered for 30 min, respectively at 24 h before TVOR and 2h 
before ET. The acupoints included SP10 (Xuehai, bilateral), SP8 (Diji, bilateral), LR3 (Taichong, 
bilateral), ST36 (Zusanli, bilateral), EX-CA1 (Zigong, bilateral), RN4 (Guanyuan), PC6 (Neiguan, 
bilateral) and RN12 (Zhongwan). Based on different frequencies of TEAS, patients were 
grouped into a TEAS-2 Hz group, a TEAS-100 Hz group and a TEAS-2/100 Hz group. Patients 
in the control group only received routine IVF treatment and no TEAS were applied on them. 
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Primary and secondary outcome measures: The number of mature oocytes, normally 
fertilized oocytes and good-quality embryos were used to evaluate oocyte developmental 
competence of the patients. Data of clinical pregnancy rate (CPR), implantation rate (IR) and 
live birth rate (LBR) were also obtained. The levels of neuropeptide Y (NPY), transforming 
growth factor alpha and granulocyte colony-stimulating factor in the follicular fluids were 
measured with enzyme-linked immunosorbent assay (ELISA). 
Results: No significant differences were found between the control, TEAS-2 Hz, TEAS-100 Hz 
and TEAS-2/100 Hz groups on the numbers of metaphase II oocytes, normally fertilized 
zygotes, early cleavage embryos or good quality embryos (P>0.05). However, the CPR, IR and 
LBR of the TEAS-2/100 Hz group were significantly higher than those of the other groups, 
respectively (P<0.05). The NPY levels in the follicular fluids of TEAS-2/100 Hz group were 
significantly higher than those of the other groups (P<0.05). 
Conclusion: TEAS using a frequency of 2/100 Hz could help to improve the IVF outcomes 
partly by increasing NPY levels in the follicular fluids. 
 
Key words: Transcutaneous electrical acupoint stimulation (TEAS), in vitro fertilization (IVF), 
clinical pregnancy rate (CPR), implantation rate (IR), live birth rate (LBR).1 
 
 
                                                             
TEAS: Transcutaneous electrical acupoint stimulation; IVF: In vitro fertilization; CPR: Clinical pregnancy rate; 
IR: Implantation rate; LBR: Live birth rate; NPY: Neuropeptide Y; ELISA: Enzyme-linked immunosorbent assay; 
HSG: Hysterosalpingogram; LH: Luteinizing hormone; FSH: Follicle stimulating hormone; E2: Estradiol; TT: 
Total testosterone; PRL: Prolactin; ART: Assisted reproductive technology; WHO: World Health Organization; 
CONSORT: Consolidated Standards of Reporting Trials; STRICTA: Standards for Reporting Interventions in 
Clinical Trials of Acupuncture; TVOR: Trans-vaginal oocyte retrieval; ET: Embryo transfer; COH: Controlled 
ovarian hyperstimulation; HCG: Human chorionic gonadotropin; TGF-alpha: Transforming growth factor alpha; 
G-CSF: Granulocyte colony-stimulating factor; GnRH: Gonadotropin-releasing hormone; CSF3: 
Colony-stimulating factor 3. 
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Introduction 
In vitro fertilization (IVF) is an important treatment for infertility, and over 300,000 cycles of 
IVF are performed each year in Europe.1 In recent years, although some equipment, 
techniques and drug therapies have been developed for improving the outcomes of IVF, the 
progress in developing safe and effective therapies has been limited.2,3 Many infertile 
women have now turned to complementary and alternative medicine as an adjuvant therapy 
to improve the outcomes when they undergo IVF treatment.4 Acupuncture, as an effective 
non-pharmacological therapy, has been chosen by many infertile couples undergoing 
infertility treatment.3,5-8 It is reported that “fertility problems” is the second most common 
health condition for which people choose acupuncture treatment in the UK.9 
Acupuncture could improve the reproductive outcomes of IVF.10,11 However, in the 
traditional acupuncture treatment, patients’ skin is pierced with the needles, which can lead 
to certain adverse effects and can affect acupuncture utilization. One study on the incidence 
of adverse effects during acupuncture therapy showed hemorrhage was the main side effect 
with a rate of 2.9%.12 Another study found that bleeding (6.1%), pain (1.7%) and vegetative 
symptoms (0.7%) were common adverse effects of acupuncture.13 These side effects may be 
reasons for dropout acupuncture in clinical studies14 or for decreased utilization in clinical 
practice. 
Transcutaneous electrical acupoint stimulation (TEAS) uses self-adhesive electrodes instead 
of the needles to stimulate acupoints with electric current.15 Different frequencies of TEAS 
can generate different biological effects. Because of the advantages of noninvasiveness and 
painlessness, TEAS recently has been a popular treatment in many conditions, including pain, 
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depression, cancer, and withdrawal syndrome.16-19 The present prospective, randomized and 
controlled trial was designed to investigate whether TEAS can improve IVF outcomes for 
infertile women with bilateral tubal blockage and to explore the possible underlying 
mechanism. 
Methods 
Subjects  
Over a five-month period (May 1, 2014 to September, 30, 2014), we screened 657 infertile 
women with bilateral tubal blockage who were referred to a university hospital for IVF. 
Among the patients screened, 162 women did not meet the inclusion criteria. Eleven women 
did not  consent to treatment, and three women were excluded for other reasons. Finally, 
481 infertile women with bilateral tubal blockage were included in the study. The subjects 
were randomized into a control group, a TEAS-2 Hz group, a TEAS-100 Hz group or a 
TEAS-2/100 Hz group using computer generated randomization that randomized numbers 
into four groups with a proportion of 1:1:1:1. The random allocation sequence was 
concealed until the interventions were assigned. A nurse enrolled the participants and 
assigned them to their groups. The IVF clinicians and laboratory staff were blinded to the 
group assignment. Ethical permission to conduct the study was obtained from the 
Institutional Review Board of Reproductive Medicine. The aim and methodology of the study 
were explained to the patients in detail. Voluntary participation was requested and 
informed written consents were obtained from all of the participants.  
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The subjects included in the study were infertile women with bilateral tubal blockage 
who were referred to our department for IVF. The bilateral tubal blockage was determined 
by hysterosalpingogram (HSG). Subjects were otherwise healthy women with regular 
menstrual cycles and normal sex hormone levels [luteinizing hormone (LH): 3.80-20.00 IU/L; 
follicle stimulating hormone (FSH): 3.80-17.20 IU/L; estradiol (E2): 100.00-275.00 pmol/L; 
total testosterone (TT): 0.30-3.00 nmol/L; prolactin (PRL): 5.00-30.00 ng/mL] and no other 
pelvic pathology.. No structural abnormalities of uterus and ovaries were found by vaginal 
ultrasound or laparoscopy. None of the women had received salpingectomy or assisted 
reproductive technology (ART) therapy before. We excluded patients with neurologic, mood 
or psychiatric disorders; patients who were taking any tranquilizers; patients who were 
receiving acupressure or acupuncture therapy; patients with a history of smoking or drinking; 
and patients who underwent preimplantation genetic diagnosis or preimplantation genetic 
screening. All the partners of the women had normal spermiograms and sperm morphology 
according to the World Health Organization (WHO) criteria.  
The present study adheres to the Consolidated Standards of Reporting Trials (CONSORT) 
statement,20 and Standards for Reporting Interventions in Clinical Trials of Acupuncture 
(STRICTA).21,22 The TEAS treatment was performed by two professional acupuncturists. The 
TEAS protocol was developed based on the clinical experience in our hospital, the literature 
and consultation with six experts in Chinese medicine. The TEAS devices (HANS-100B) used 
in the study were provided at a regular price without any direct involvement of the 
manufacturer (Jisheng Medical Technology Co., Ltd, Nanjing, China). 
Group and administration  
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Thirty-minute TEAS were administered at 24 hours before trans-vaginal oocyte retrieval 
(TVOR) and 2 hours before embryo transfer (ET) respectively. Acupoints of SP10 (Xuehai, 
bilateral), SP8 (Diji, bilateral), LR3 (Taichong, bilateral), and ST36 (Zusanli, bilateral) were 
chosen before TVOR, and acupoints of EX-CA1 (Zigong, bilateral), RN4 (Guanyuan), PC6 
(Neiguan, bilateral) and RN12 (Zhongwan) were chosen before ET. TEAS was applied through 
self-adhesive surface electrodes. The standard electrodes affiliated to the TEAS device were 
applied to the denuded skin and the intensity was set strong enough to elicit visible muscle 
contraction. 
Generally, 2 Hz is chosen as a representative for low frequency, 100 Hz for high frequency, 
and 2/100 Hz for alternate low and high frequencies. According to the different frequencies 
of TEAS, patients were divided into three TEAS groups: TEAS-2 Hz group, TEAS-100 Hz group 
and TEAS-2/100 Hz group. In each group, the frequency of TEAS used before TVOR and ET 
was consistent. Patients in the control group followed the routine procedure of IVF 
treatment and no TEAS was applied. According to our pilot experiment, two treatments 
(before TVOR and ET) were sufficient to provide therapeutic benefits. Since patients could 
know whether they received treatment and detect the frequencies of TEAS, they were not 
blinded. 
Collection of the follicular fluids 
The long agonist protocol for controlled ovarian hyperstimulation (COH) was used as 
previously described.23 Briefly, COH was performed by administration of recombinant follicle 
stimulating hormone (r-FSH, Gonal-F, Serono International S.A., Geneva, Switzerland) after 
pituitary suppression with triptorelin (Serono) started in the midluteal phase of the 
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preceding cycle. The dosages of gonadotrophins were individualized according to E2 levels 
and trans-vaginally ultrasonic measurements of the follicles. When at least three follicles 
had reached the diameters of 16–18 mm, ovulation was induced by administration of 10,000 
IU human chorionic gonadotropin (HCG, Libao Biochemistry Co., Zhuhai, China). 
Trans-vaginal oocyte aspiration was performed with ultrasound guidance under general 
anesthesia 36 h after injection of HCG. The follicular fluids were sampled by trans-vaginal 
ultrasound-guided puncture and aspiration of the follicles with diameters of 16–18 mm. 
Those follicular fluids samples that did not contain any visible blood contamination were 
used in this study. The follicular fluids samples were immediately centrifuged for 10 min at 
550g. The supernatants were stored at -80°C until analysis.  
Index and method 
The oocytes’ developmental competence was evaluated by obtaining the numbers of 
metaphase II oocytes, normally fertilized zygotes and good quality embryos. The zygotes 
were checked 17-20 hours after fertilization, for two pronuclei (2PN) and polar bodies to 
assess fertilization. The good quality embryo was defined as: 7-9 cells on Day 3, <10% 
fragmentation and equally sized mononucleated blastomeres. The clinical pregnancy rate 
(CPR), the primary outcome, was defined as the presence of at least one gestational sac or 
fetal heartbeat, confirmed by trans-vaginal ultrasound. Implantation rate (IR, defined as the 
number of gestational sacs per number of transferred oocytes) and live birth rate (LBR, 
defined as the presence of a baby born alive after 24 weeks gestation) for all the patients 
were also obtained. The levels of neuropeptide Y (NPY), transforming growth factor alpha 
(TGF-alpha) and granulocyte colony-stimulating factor (G-CSF) in the follicular fluids were 
9 
 
measured with enzyme-linked immunosorbent assay (ELISA, RayBio, GA, U.S.A).  
Sample size and data analysis 
The sample size was analyzed using Power Analysis and Sample Size (PASS 11.0). According 
to the records, a CPR of 0.38 was estimated in the control population and a CPR of 0.40, 0.42 
and 0.57 was respectively estimated in TEAS-2 Hz population, TEAS-100 Hz population, and 
TEAS-2/100 Hz population. A sample size of 393 achieves 90% power to detect an effect size 
(W) of 0.19 using a 3 degrees of freedom Chi-Square Test with a significance level (alpha) of 
0.05.  
Data were analyzed by an independent statistician using Statistical Package for Social 
Sciences (SPSS 19.0 for Windows). One-way analysis of variance (ANOVA) was used to 
evaluate statistical significances of continuous data. Chi-square test was used to compare 
categorical data. For all analyses, significance was set at P<0.05. 
 
Results 
The sample population and baseline characteristics  
After the included 481 infertile women with bilateral tubal blockage were randomized, the 
control group had 120 cases, TEAS-2 Hz group 121 cases, TEAS-100 Hz group 119 cases and 
TEAS-2/100 Hz group 121 cases. The ET treatment was conducted three days after TVOR. In 
the statistical analysis, 11, 13, 8 and 7 cases respectively in the control group, TEAS-2 Hz 
group, TEAS-100 Hz group and TEAS-2/100 Hz group were excluded, as these patients did 
not complete ET. As shown in Table 1, there were no significant differences between the 
control group, TEAS-2 Hz group, TEAS-100 Hz group and TEAS-2/100 Hz group on all the 
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baseline characteristics (P>0.05).  
 
Table 1. The baseline characteristics of the participants 
Items 
Control group 
(n=109) 
TEAS-2 Hz group 
(n=108) 
TEAS-100 Hz group 
(n=111) 
TEAS-2/100 Hz  
group 
(n=114) 
Ages (years) 29.816.17 31.225.92 30.445.82 31.166.09 
BMI (kg/m2) 21.536.28 22.976.59 21.775.98 23.146.55 
Duration of infertility (year) 6.494.17 5.843.99 6.304.01 5.924.49 
Day-3 LH(nmol/L) 5.652.83 6.123.04 5.972.96 6.253.39 
Day-3 FSH (nmol/L) 7.423.15 6.972.82 7.083.11 7.332.90 
Day-3 TT(pmol/L) 1.410.08 1.410.11 1.420.09 1.430.11 
Day-3 E2(pmol/L) 157.8149.24 146.1243.89 150.9746.25 155.6745.04 
Cycle length (days) 33.548.51 34.927.92 32.878.53 35.738.82 
rFSH administered (IU) 2409.36786.73 2327.05801.05 2419.55835.67 2431.18822.17 
Induction length (days) 9.982.58 9.822.37 10.322.89 10.172.74 
Number of oocytes 15.327.05 14.876.98 15.026.73 14.587.67 
Number of follicles >14mm 13.555.64 12.986.02 13.846.29 13.225.83 
Education level     
  High 71 / 109 (65.14%) 68 / 108 (62.96%) 70 / 111(63.06%) 73 / 114 (64.04%) 
  Medium 30 / 109 (27.52%) 28 / 108 (25.93%) 31 / 111 (27.93%) 29 / 114 (25.44%) 
  Low 8 / 109 (7.34%) 12 / 108 (11.11%) 10 / 111 (9.01%) 12 / 114 (10.53%) 
Note: Data were shown as mean ± S.D. TEAS: transcutaneous electrical acupoint stimulation; 
BMI: body mass index; Day-3: the 3rd day of spontaneous menstrual cycle; LH: luteinizing 
hormone; FSH: follicle stimulating hormone; TT: total testosterone; E2: estradiol; r-FSH: 
recombinant FSH. 
 
The oocytes developmental competence  
As shown in Table 2, there were no significant differences between the control, TEAS-2 Hz, 
TEAS-100 Hz and TEAS-2/100 Hz groups on the numbers of metaphase II oocytes, normally 
fertilized zygotes or good quality embryos (P>0.05).   
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Table 2: The oocytes developmental competence and the outcomes of in vitro fertilization. 
Items 
Control group 
(n=109) 
TEAS-2 Hz group 
(n=108) 
TEAS-100 Hz group 
(n=111) 
TEAS-2/100 Hz  
group 
(n=114) 
Number of metaphase II 
oocytes 
11.674.19 11.854.78 10.954.34 11.214.59 
Number of normally fertilized 
zygotes  
7.625.73 8.046.11 7.905.88 7.486.02 
Number of good quality 
embryos 
3.492.23 3.312.19 3.622.05 3.541.99 
Clinical pregnancy rate (%) 46 / 109 (42.20%) 46 / 108 (42.59%) 47 / 111 (42.34%)  
64 / 114 (56.14%) * # 
$ 
Implantation rate (%)                             54 / 217 (24.88%) 55 / 219 (25.11%) 53 / 223 (23.77%) 
82 / 231 (35.50%) * # 
$ 
Live birth rate (%) 38 / 109 (34.86%) 38 / 108 (35.19%) 39 / 111 (35.14%)  
55 / 114 (48.25%) * # 
$ 
Note: Data were shown as mean ± S.D. *P<0.05, compared with the control group; #P<0.05 
compared with the TEAS-2 Hz group; $P<0.05 compared with the TEAS-100 Hz group. TEAS: 
transcutaneous electrical acupoint stimulation. 
 
IVF outcomes 
As shown in Table 2, the CPR, IR and LBR of TEAS-2/100 Hz group were significantly higher 
than those of the other three groups respectively (P<0.05). No significant differences existed 
between the control, TEAS-2 Hz and TEAS-100 Hz groups on the CPR, IR or LBR (P>0.05) 
(Table 2). 
 
NPY, TGF-alpha and G-CSF levels in the follicular fluids 
As shown in Table 3, the NPY levels in the follicular fluids of the TEAS-2/100 Hz group were 
significantly higher than those of the other three groups respectively (P<0.05). In the 
TEAS-100 Hz group, the NPY levels in the follicular fluids were significantly higher than those 
of the control and the TEAS-2 Hz groups (P<0.05) and no marked differences existed 
between the control and the TEAS-2 Hz groups (P>0.05). There were no significant 
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differences between all the groups on the TGF-alpha or G-CSF levels in the follicular fluids 
(P>0.05).  
 
Table 3: The levels of neuropeptide Y, transforming growth factor alpha and granulocyte 
colony-stimulating factor in the follicular fluids. 
Items 
Control group 
(n=109) 
TEAS-2 Hz group 
(n=108) 
TEAS-100 Hz group 
(n=111) 
TEAS-2/100 Hz  
group 
(n=114) 
NPY(ng/ml) 23.707.95 25.668.19  34.079.10*# 49.7013.53* # $ 
TGF-alpha (pg/ml) 29.136.38 30.617.23 30.046.76 29.936.42 
G-CSF (pg/ml) 84.7112.96 85.3213.08 83.7612.88 85.0713.19 
Note: Data were shown as mean ± S.D. *P<0.05, compared with the control group; #P<0.05 
compared with the TEAS-2 Hz group; $P<0.05 compared with the TEAS-100 Hz group. TEAS: 
transcutaneous electrical acupoint stimulation; NPY: neuropeptide Y; TGF-alpha: 
transforming growth factor alpha; G-CSF: granulocyte colony-stimulating factor.    
 
Adverse events 
No side effects of the treatment were reported in any of the groups during the research and 
the follow-up period.  
Discussion 
In the present study, 481 infertile patients with bilateral tubal blockage referred for IVF were 
included to investigate whether TEAS can improve IVF outcomes. Patients were divided into 
four groups: TEAS-2 Hz group, TEAS-100 Hz group, TEAS-2/100 Hz group and control group. 
We found the CPR, IR, LBR and NPY levels of the TEAS-2/100 Hz group were significantly 
higher than those of the other groups. However, there were no significant differences of the 
numbers of metaphase II oocytes, normally fertilized zygotes, early cleavage embryos and 
good quality embryos among the four groups. 
TEAS is a new technique integrating traditional electro-acupuncture and new knowledge 
from advancing science. It can activate nerve endings and generate action potentials by 
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electrical stimulation. These signals, transmitted to spinal cord and brain, appear to 
stimulate the central nervous system to generate specific chemical substances to produce 
physiological effects. 24,25 Effective frequency ranges from 2 Hz to 100 Hz for TEAS, and 
stimulation with different frequencies may generate totally different biological effects.26 
Previous studies showed different frequencies of TEAS could generate totally different 
biological effects: low-frequency (2 Hz) electrical stimulation promoted the release of 
enkephalins, endorphins and endomorphin in the brain to interact with the μ- and δ-opioid 
receptors; high-frequency (100 Hz) promoted the release of dynorphin in spinal cord to 
interact with the κ opioid receptors; and alternate low and high frequencies (2/100 Hz) 
promoted the release of all four kinds of endogenous opioid peptides.27 TEAS treatment was 
found to improve CPR in the patients with decreased ovarian reserve during IVF.28 In the 
present study, we found TEAS using a frequency of 2/100 Hz significantly improved the CPR, 
IR and LBR of the IVF women. 
The impact of acupuncture and electro-acupuncture on the clinical outcomes of IVF has been 
well studied. Positive effects have been shown in modulating the ovarian blood flow and the 
functions of the hypothalamus-pituitary-ovary system.29-31 One randomized, prospective, 
controlled clinical study found that clinical pregnancy rate and ongoing pregnancy rate more 
than doubled by luteal-phase acupuncture.32 Another study showed acupuncture on the day 
of ET increased clinical pregnancy and ongoing pregnancy rates by about 50%.11 However, 
because the acupoints, acupuncturists, patients and treatment time in these studies were 
varied, it was difficult to compare acupuncture with TEAS. 
For patients who are unwilling to receive invasive or painful acupuncture treatment, TEAS is 
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potentially a good choice. In the TEAS treatment, the skin electrodes are placed on the 
patients’ acupoints, instead of piercing the skin with the traditional acupuncture needles. 
TEAS can also increase the reproducibility of the acupuncture-like stimulation.24,25 Compared 
with acupuncture, TEAS is easier to use:  patients can even potentially use TEAS on their 
own under the guidance of acupuncturists. We did not find any adverse events in any group 
during the research and the follow-up period. This indicates TEAS is a safe intervention to 
improve the outcomes of IVF.  
In the study, the levels of NPY, TGF-alpha and G-CSF in the follicular fluids of the IVF patients 
were measured to explore the potential mechanism underlying TEAS improving the 
outcomes of IVF. NPY may represent a link between nutrition and reproduction at the level 
of the central nervous system,33 and may serve as one of the molecular signlas integrating 
the control of metabolism and reproduction.34 NPY may play a role in positive regulation of 
gonadotropin-releasing hormone (GnRH) throughout the neural axis and also up-regulate 
the LH cells in the pituitary.35 NPY is also a key factor during the follicular growth, ovulation 
and regulating the functions of the hypothalamic-pituitary-ovarian axis.36-41 
Electro-acupuncture was found to significantly improve the levels of NPY in the follicular 
fluids of the patients.42 The result is consistent with the present study.  
TGF-alpha plays an important role in regulating the growth of follicles and the 
maturation of oocyte.43-45 G-CSF, also known as colony-stimulating factor 3 (CSF3), is a 
biomarker of human oocyte developmental competence for embryo implantation.46-49 It has 
a higher discriminatory power to predict the ongoing pregnancy in multivariate logistic 
regression analysis for G-CSF levels in the follicular fluids, compared with embryo 
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morphology.50 It was found that the quality of porcine oocyte and embryonic viability were 
significantly improved when adding the human recombination G-CSF into porcine in vitro 
maturation medium.51 In the present study, the NPY levels in the follicular fluids of the 
TEAS-2/100 Hz group were significantly higher than those of the other groups, and there 
were no significant differences between all the four groups on the TGF-alpha or G-CSF levels 
in the follicular fluids. This could indicate that NPY, as opposed to one of the othese other 
molecules examined, may be the primary mediator of the improvement in outcomes of the 
IVF patients.  
Although it has been reported that TEAS may improve IVF outcomes, the underlying 
mechanisms are not clear. Several mechanisms have been suggested to explain the role of 
acupuncture in IVF, such as increasing blood flow and ovarian steroid hormone secretion, 
reducing anxiety of patients, etc. In the present study, we investigated whether TEAS may 
improve IVF outcomes by influencing oocyte developmental competence, which is defined as 
the ability of oocyte to complete meiosis and undergo fertilization, embryo genesis and term 
development. We did not find any differences between the control, TEAS-2 Hz, TEAS-100 Hz 
and TEAS-2/100 Hz groups on the numbers of metaphase II oocytes, normally fertilized 
zygotes, early cleavage embryos or good quality embryos. Moreover, follicular fluid levels of 
TGF-alpha (reflecting oocyte maturation) and G-CSF (a biomarker of human oocyte 
developmental competence) showed no significant differences between all the four groups, 
indicating that TEAS influences IVF outcomes through mechanisms other than improving 
oocyte quality.  
In conclusion, TEAS using a frequency of 2/100 Hz could help to improve the IVF outcomes 
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partly by increasing the NPY levels in the follicular fluids. These findings provide preliminary 
evidence to suggest that TEAS may be a new option for clinicians and infertile women during 
IVF treatment. Limitations of this study include lack of a placebo group, small sample size, 
short research period and the fact that patients included were only those with bilateral tubal 
blockage. A larger randomized, multicenter, double-blinded and placebo-controlled trial 
should be conducted in the near future to further confirm the effects of TEAS on the IVF 
outcomes and to further explore the potential underlying mechanism of this effect.  
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